A coordinated and regulated response involving all branches of adaptive immunity (CD4+, CD8+ and antibody responses) is likely required to reduce COVID-19 severity, with the cellular response being key for both initiating the adaptive response and for controlling the acute infection (29). The gene discussed is CD4; the disease is COVID-19.